Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Compounding pharmacies have remained a steady source of semaglutide since the FDA faced repeated shortages of branded Ozempic and Wegovy. Unlike mass-manufactured versions, compounded semaglutide is prepared by licensed professionals in state-regulated facilities and has supported thousands of patients pursuing weight loss treatment without waiting lists or insurance barriers.
How Licensed Compounding Pharmacies Manufacture Semaglutide Today
Licensed 503A compounding pharmacies produce semaglutide by combining pharmaceutical-grade ingredients under strict quality controls mandated by each state's pharmacy board. These facilities follow USP <797> and <825> standards for sterile and non-sterile compounding, ensuring each batch meets potency, purity, and safety benchmarks before dispensing. PlexusDx works exclusively with 503A compounders—never 503B manufacturers—to guarantee personalized preparation tailored to individual patient needs.
The compounding process begins with pharmaceutical-grade semaglutide powder or base solution, which is then mixed with appropriate carriers and packaged for injection or oral delivery. Each prescription is prepared after a patient consultation, meaning dosing adjustments and formulation changes happen quickly without waiting for new stock shipments. This on-demand model has proven essential during periods when branded GLP-1 medications face supply constraints.
Regulatory Status and Legal Standing of Compounded Semaglutide
Compounded semaglutide remains legal under the Food and Drug Administration's 503A pharmacy compounding guidance, which permits licensed compounders to prepare medications when there is documented drug shortage, patient-specific need, or therapeutic equivalent unavailability. While compounded medications are not FDA-approved in the same way as branded drugs, they operate within an established legal framework that has been reinforced by state pharmacy boards and federal oversight. The FDA distinguishes between 503A compounders (state-licensed, patient-specific preparation) and 503B manufacturers (wholesale, commercial production), and PlexusDx exclusively partners with 503A facilities.
State pharmacy boards conduct regular inspections and enforce compliance with compounding standards, inspections, and adverse event reporting. Patients selecting compounded semaglutide from a licensed 503A compounder access a product created under the same regulatory scrutiny as traditional pharmacy services, with documented chain-of-custody and quality assurance protocols.
Why Compounded Semaglutide Remains a Trusted Option for Weight Loss
Compounded semaglutide offers flexibility that branded products cannot match, including customized dosing schedules, multiple delivery formats (injection or oral), and rapid formulation changes based on individual tolerance and response. Patients often report faster access to treatment with compounded options, since there are no nationwide supply chain bottlenecks or insurance pre-authorization delays. PlexusDx Compounded Semaglutide Injection starts at $149 per month and accommodates dose adjustments without price increases—a transparent pricing model designed to remove financial barriers to consistent treatment.
The affordability of compounded semaglutide has democratized access to GLP-1 weight loss therapy for patients without insurance coverage or those seeking to avoid high out-of-pocket costs. Many patients find compounded products effective for achieving meaningful weight reduction and improved metabolic health, supported by the same active ingredient and mechanism as branded formulations.
PlexusDx Compounding Standards and Quality Assurance
PlexusDx partners with licensed 503A compounding pharmacies that meet or exceed USP standards for sterile and non-sterile preparations. Each batch undergoes potency verification, sterility testing, and endotoxin analysis before reaching patients, with complete documentation of ingredients, mixing logs, and quality control results. PlexusDx tracks every prescription through its partner network to ensure consistent quality and rapid communication about any formulation updates or supply adjustments.
Patients enrolling in PlexusDx treatment receive detailed counseling on proper storage, injection technique (for injectable products), and what to expect during dose escalation phases. The platform integrates telehealth consultations with licensed practitioners who monitor clinical response and adjust therapy based on weight loss progress, tolerance to side effects, and metabolic biomarkers—personalization that reflects the precision medicine foundation of compounded care.
Genetic Testing and Personalized Semaglutide Response
Not all patients respond to semaglutide at the same dose or experience the same side effect profile, a reality rooted in genetic variation across peptide-pathway genes. PlexusDx offers the Precision Peptide Genetic Test, which examines key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to predict individual GLP-1 sensitivity and weight loss capacity. This test maps 14 distinct pathways, 49 peptides, and 150+ genetic insights that inform whether a patient may need higher or lower starting doses, or whether dual-compound therapy (semaglutide plus tirzepatide) offers better outcomes.
Genetic insights transform compounded semaglutide from a one-size-fits-all approach into a precision tool calibrated to each person's molecular biology. Patients who undergo genetic testing often titrate more predictably through their dose range and experience fewer side effects because their medication regimen aligns with their genetic predispositions rather than population averages.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide still being made by pharmacies in 2024?
Yes, licensed 503A compounding pharmacies continue to manufacture semaglutide under state and federal oversight. PlexusDx partners with these facilities to provide compounded semaglutide injection starting at $149 per month, with no insurance requirement and HSA/FSA eligibility.
How is compounded semaglutide different from branded Ozempic or Wegovy?
Compounded semaglutide is prepared individually by licensed pharmacies after a patient consultation, allowing rapid dose adjustments and custom delivery formats. Branded versions are mass-manufactured and subject to supply chain limitations.
Is compounded semaglutide FDA-approved?
Compounded semaglutide is not FDA-approved in the traditional sense, but it is legal and regulated under FDA 503A compounding guidance. It is prepared by state-licensed pharmacies following strict quality and safety standards, making it a legitimate option for weight loss treatment.
What side effects should I expect from compounded semaglutide?
Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite—most mild and dose-dependent. These typically diminish within 1–2 weeks as the body adjusts. PlexusDx practitioners monitor side effect tolerance during dose escalation and can adjust the schedule or formulation if needed.
Can genetic testing help me succeed with compounded semaglutide?
Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict your semaglutide sensitivity and weight loss capacity. This insight helps your provider personalize your starting dose and anticipate side effects, improving your likelihood of sustained weight loss at a lower price point.
How much does PlexusDx Compounded Semaglutide cost?
PlexusDx Compounded Semaglutide Injection starts at $149 per month across all commitment tiers, with the price remaining flat even as your dose increases. No insurance is required, and the medication is HSA/FSA eligible, making it accessible for most budgets.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Which GLP-1 is Most Effective for Weight Loss?
How Many Units is 2.4 mg of Semaglutide? Understanding Dosage and Administration